These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 14255167)

  • 1. EFFECTS OF D-AMPHETAMINE UPON BRAIN AMINE CONTENT AND LOCOMOTOR ACTIVITY OF MICE.
    SMITH CB
    J Pharmacol Exp Ther; 1965 Jan; 147():96-102. PubMed ID: 14255167
    [No Abstract]   [Full Text] [Related]  

  • 2. ENHANCEMENT BY RESERPINE AND ALPHA-METHYL DOPA OF THE EFFECTS OF D-AMPHETAMINE UPON THE LOCOMOTOR ACTIVITY OF MICE.
    SMITH CB
    J Pharmacol Exp Ther; 1963 Dec; 142():343-50. PubMed ID: 14098331
    [No Abstract]   [Full Text] [Related]  

  • 3. THE ROLE OF ENDOGENOUS NOREPINEPHRINE IN THE TOXICITY OF D-AMPHETAMINE IN AGGREGATED MICE.
    MOORE KE
    J Pharmacol Exp Ther; 1964 Apr; 144():45-51. PubMed ID: 14191465
    [No Abstract]   [Full Text] [Related]  

  • 4. EFFECTS OF D-AMPHETAMINE UPON OPERANT BEHAVIOR OF PIGEONS: ENHANCEMENT BY RESERPINE.
    SMITH CB
    J Pharmacol Exp Ther; 1964 Nov; 146():167-74. PubMed ID: 14236926
    [No Abstract]   [Full Text] [Related]  

  • 5. MECHANISM OF ACTION OF PSYCHOMOTOR STIMULANT DRUGS. SIGNIFICANCE OF DOPAMINE IN LOCOMOTOR STIMULANT ACTION.
    VAN ROSSUMJ ; HURKMANS AT
    Int J Neuropharmacol; 1964 May; 3():227-39. PubMed ID: 14336531
    [No Abstract]   [Full Text] [Related]  

  • 6. EFFECTS OF D-AMPHETAMINE AND RESTRAINT ON THE CONTENT OF NOREPINEPHRINE AND DOPAMINE IN RAT BRAIN.
    MOORE KE; LARIVIERE EW
    Biochem Pharmacol; 1963 Nov; 12():1283-8. PubMed ID: 14078917
    [No Abstract]   [Full Text] [Related]  

  • 7. MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN.
    LAVERTY R; SHARMAN DF
    Br J Pharmacol Chemother; 1965 Jun; 24(3):759-72. PubMed ID: 14340930
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 9. EFFECT OF RESERPINE ON THE METABOLIC CENTRES.
    PFEIFER AK; VIZI ES; SATORY E; GALAMBOS E
    Arch Int Pharmacodyn Ther; 1964 May; 149():126-35. PubMed ID: 14169876
    [No Abstract]   [Full Text] [Related]  

  • 10. FUNCTION AND METABOLISM OF CATECHOLAMINES IN THE BRAIN.
    MATSUOKA M
    Jpn J Pharmacol; 1964 Jun; 14():181-93. PubMed ID: 14215546
    [No Abstract]   [Full Text] [Related]  

  • 11. BIOCHEMICAL MECHANISM OF AMPHETAMINE TOXICITY IN ISOLATED AND AGGREGATED MICE.
    LAL H; CHESSICK RD
    Life Sci (1962); 1964 Apr; 3():381-4. PubMed ID: 14172955
    [No Abstract]   [Full Text] [Related]  

  • 12. EFFECT OF TYRAMINE, RESERPINE AND COCAINE ON THE NORADRENALINE RELEASE AND UPTAKE OF THE PERFUSED RABBIT KIDNEY.
    INOUYE A; TANAKA I
    Acta Physiol Scand; 1964 Dec; 62():359-63. PubMed ID: 14252571
    [No Abstract]   [Full Text] [Related]  

  • 13. ANTAGONISM OF RESERPINE BEHAVIORAL DEPRESSION BY D-AMPHETAMINE.
    RECH RH
    J Pharmacol Exp Ther; 1964 Dec; 146():369-76. PubMed ID: 14254332
    [No Abstract]   [Full Text] [Related]  

  • 14. EFFECTS OF CENTRALLY ACTING DRUGS ON CONFINEMENT MOTOR ACTIVITY.
    TEDESCHI DH; FOWLER PJ; CROMLEY WH; PAULS JF; EBY RZ; FELLOWS EJ
    J Pharm Sci; 1964 Sep; 53():1046-50. PubMed ID: 14234892
    [No Abstract]   [Full Text] [Related]  

  • 15. BRAIN MONOAMINE LEVELS AND BEHAVIOUR DURING LONG-TERM ADMINISTRATION OF RESERPINE.
    HAEGGENDAL J; LINDQVIST M
    Int J Neuropharmacol; 1964 Apr; 3():59-64. PubMed ID: 14334597
    [No Abstract]   [Full Text] [Related]  

  • 16. ANTAGONISM OF THE BLOCKING ACTION OF BRETYLIUM AND GUANETHIDINE ON THE PRESSOR EFFECT OF PHYSOSTIGMINE IN THE RAT.
    GOKHALE SD; GULATI OD; JOSHI NY
    Br J Pharmacol Chemother; 1965 Jun; 24(3):624-31. PubMed ID: 14340916
    [No Abstract]   [Full Text] [Related]  

  • 17. ANTAGONISM OF CERTAIN EFFECTS OF CATECHOLAMINE-DEPLETING AGENTS BY ANTIDEPRESSANT AND RELATED DRUGS.
    STONE CA; PORTER CC; STAVORSKI JM; LUDDEN CT; TOTARO JA
    J Pharmacol Exp Ther; 1964 May; 144():196-204. PubMed ID: 14183431
    [No Abstract]   [Full Text] [Related]  

  • 18. BEHAVIORAL EFFECTS OF INTERACTING IMIPRAMINE AND OTHER DRUGS WITH D-AMPHETAMINE, COCAINE, AND TETRABENAZINE.
    SCHECKEL CL; BOFF E
    Psychopharmacologia; 1964 Feb; 5():198-208. PubMed ID: 14138755
    [No Abstract]   [Full Text] [Related]  

  • 19. DISCLOSURE OF LABILE MONOAMINE FRACTIONS IN BRAIN AND THEIR CORRELATION TO BEHAVIOUR.
    HAEGGENDAL J; LINGVIST M
    Acta Physiol Scand; 1964 Apr; 60():351-7. PubMed ID: 14157538
    [No Abstract]   [Full Text] [Related]  

  • 20. DRUG-INDUCED CHANGES OF THE METABOLISM OF 5-HYDROXYTRYPTAMINE IN THE BRAIN OF X-RAY-TREATED RATS.
    PALAIC D; SUPEK Z
    J Neurochem; 1965 Apr; 12():329-33. PubMed ID: 14336232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.